Physician profile
Masha Sachenko
NPI 1487914719
$1,659.05
in general payments reported to CMS, 2019-2025
26 companies · $361 in 2025
The $361 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.74 · 2020: $112 · 2021: $240 · 2022: $202 · 2023: $466 · 2024: $252 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,078.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $223.37 | 2020-2023 | Orilissa, Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $207.07 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $176.94 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $127.08 | 2021-2025 | |
| Channel Medsystems, INC. | $115.44 | 2023 | |
| Astellas Pharma US INC | $108.34 | 2025 | Veozah |
| Hologic Sales and Service, LLC | $106.53 | 2022-2025 | Thinprep 2000 Processor, Aptima, Acessa Provu System |
| Medtronic, INC. | $96.20 | 2023 | Truclear |
| Shield Therapeutics INC | $62.57 | 2023-2024 | Accrufer |
| Vertex Pharmaceuticals Incorporated | $55.72 | 2025 | |
| Coopersurgical, INC. | $49.69 | 2021-2024 | Summit Doppler |
| Novo Nordisk INC | $48.08 | 2021-2023 | Wegovy |
| Intra-Sana Laboratories | $37.66 | 2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Therapeuticsmd, INC. | $36.61 | 2020-2021 | |
| Lilly USA, LLC | $32.40 | 2025 | Zepbound |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $23.48 | 2024 | Femring, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $20.69 | 2023 | |
| Lupin INC. | $18.55 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $18.11 | 2021 | |
| Baxter Healthcare | $16.48 | 2025 | Perclot |
| Amag Pharmaceuticals, INC. | $15.22 | 2019 | |
| Avion Pharmaceuticals | $14.20 | 2021 | |
| Roche Diagnostics Corporation | $13.44 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.38 | 2020 | |
| Allergan, INC. | $11.52 | 2019 | |
| Organon LLC | $10.28 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Masha Sachenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.